These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23931634)

  • 1. Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter.
    Gilbert IH
    Parasitology; 2014 Jan; 141(1):28-36. PubMed ID: 23931634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
    Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug transport and drug resistance in African trypanosomes.
    Mäser P; Lüscher A; Kaminsky R
    Drug Resist Updat; 2003 Oct; 6(5):281-90. PubMed ID: 14643298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis.
    Wring S; Gaukel E; Nare B; Jacobs R; Beaudet B; Bowling T; Mercer L; Bacchi C; Yarlett N; Randolph R; Parham R; Rewerts C; Platner J; Don R
    Parasitology; 2014 Jan; 141(1):104-18. PubMed ID: 24007596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diamidines for human African trypanosomiasis.
    Paine MF; Wang MZ; Generaux CN; Boykin DW; Wilson WD; De Koning HP; Olson CA; Pohlig G; Burri C; Brun R; Murilla GA; Thuita JK; Barrett MP; Tidwell RR
    Curr Opin Investig Drugs; 2010 Aug; 11(8):876-83. PubMed ID: 20721830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of 28DAP010, a novel diamidine for treatment of second-stage African sleeping sickness.
    Wenzler T; Yang S; Patrick DA; Braissant O; Ismail MA; Tidwell RR; Boykin DW; Wang MZ; Brun R
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4452-63. PubMed ID: 24867978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
    Jones AJ; Kaiser M; Avery VM
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1859-61. PubMed ID: 26666915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy of human African trypanosomiasis.
    Burchmore RJ; Ogbunude PO; Enanga B; Barrett MP
    Curr Pharm Des; 2002; 8(4):256-67. PubMed ID: 11860365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Veterinary link to drug resistance in human African trypanosomiasis?
    Barrett MP
    Lancet; 2001 Aug; 358(9282):603-4. PubMed ID: 11530144
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human trypanolytic factor: a drug shaped naturally.
    Vanhamme L
    Infect Disord Drug Targets; 2010 Aug; 10(4):266-82. PubMed ID: 20429865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
    Hiltensperger G; Jones NG; Niedermeier S; Stich A; Kaiser M; Jung J; Puhl S; Damme A; Braunschweig H; Meinel L; Engstler M; Holzgrabe U
    J Med Chem; 2012 Mar; 55(6):2538-48. PubMed ID: 22376072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phenomenon of treatment failures in Human African Trypanosomiasis.
    Brun R; Schumacher R; Schmid C; Kunz C; Burri C
    Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro and In Vivo Trypanocidal Efficacy of Synthesized Nitrofurantoin Analogs.
    Munsimbwe L; Seetsi A; Namangala B; N'Da DD; Inoue N; Suganuma K
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34199682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.
    Barrett MP; Boykin DW; Brun R; Tidwell RR
    Br J Pharmacol; 2007 Dec; 152(8):1155-71. PubMed ID: 17618313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
    Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
    Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activities of 2-aminopyrazines and 2-aminopyridines in experimental models of human African trypanosomiasis.
    Vodnala SK; Lundbäck T; Sjöberg B; Svensson R; Rottenberg ME; Hammarström LG
    Antimicrob Agents Chemother; 2013 Feb; 57(2):1012-8. PubMed ID: 23254423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei.
    Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
    Planta Med; 2012 Apr; 78(6):553-6. PubMed ID: 22331812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy against human African trypanosomiasis: is there a road to success?
    Burri C
    Parasitology; 2010 Dec; 137(14):1987-94. PubMed ID: 20961469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.